Related Experiment Videos
Effect of ipratropium bromide on respiratory mechanics in infants with acute bronchiolitis
J Seidenberg1, I B Masters, I Hudson
1Professional Department of Thoracic Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.
Insights
Nebulized ipratropium bromide did not improve respiratory mechanics in infants with respiratory syncytial virus bronchiolitis. This study found no significant differences, questioning its use for this common infant respiratory illness.
Area of Science:
- Pediatric Pulmonology
- Neonatal Respiratory Medicine
- Pharmacology
Background:
- Acute viral bronchiolitis is a common respiratory infection in infants.
- Respiratory syncytial virus (RSV) is the primary cause of bronchiolitis.
- Current treatments for bronchiolitis are largely supportive.
Purpose of the Study:
- To evaluate the efficacy of nebulized ipratropium bromide in infants with acute RSV bronchiolitis.
- To assess the impact of ipratropium bromide on respiratory mechanics in this population.
Main Methods:
- The study included 14 infants with acute RSV bronchiolitis (mean age 20 weeks).
- Respiratory mechanics were measured using partial expiratory flow-volume curves and body plethysmography.
- Measurements were taken before and after administration of nebulized ipratropium bromide.
Main Results:
- No significant differences were observed in forced or passive respiratory mechanics post-ipratropium bromide administration.
- No specific subgroups of infants showed a positive response to the treatment.
- The drug did not alter thoracic gas volume or maximum flow at functional residual capacity.
Conclusions:
- Nebulized ipratropium bromide demonstrated no significant benefit in improving respiratory mechanics in infants with acute viral bronchiolitis.
- These findings do not support the routine use of ipratropium bromide for treating acute viral bronchiolitis in infants.
- Further research may be needed to explore potential alternative treatments or specific patient subgroups.
Abstract:
The effect of nebulized ipratropium bromide in 14 infants (mean age: 20 weeks, range: 4-41) with acute respiratory syncytial virus bronchiolitis was examined. A modified rapid chest compression technique was used to obtain partial expiratory flow-volume curves and maximum flow at functional residual capacity. Passive respiratory mechanics were assessed by brief occlusion at end inspiration. Thoracic gas volume was measured in a body plethysmograph. No significant difference was found in forced and passive respiratory mechanics pre- and post-ipratropium bromide. No subgroups could be identified. These results do not support the use of ipratropium bromide in acute viral bronchiolitis.